uniQure N.V. (NASDAQ: QURE) Stock Information | RedChip

uniQure N.V. (NASDAQ: QURE)


$15.9000
-0.0200 ( -1.06% ) 4.7K

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

Market Data


Open


$15.9000

Previous close


$15.9200

Volume


4.7K

Market cap


$780.49M

Day range


$15.6200 - $16.4490

52 week range


$3.7300 - $19.1800

SEC Filings


Form Type Description Pages Date
pre Proxies and info statements 21 Apr 12, 2024
8-k 8K-related 13 Apr 12, 2024
4 Insider transactions 1 Mar 05, 2024
4 Insider transactions 1 Mar 05, 2024
4 Insider transactions 1 Mar 05, 2024
4 Insider transactions 1 Mar 05, 2024
4 Insider transactions 1 Mar 05, 2024
10-k Annual reports 125 Feb 28, 2024
4 Insider transactions 1 Feb 28, 2024
4 Insider transactions 1 Feb 28, 2024

Latest News